1295.TWO
Price:
$94.3
Market Cap:
$3.25B
Synbio Tech, Inc. operates as a biotechnology company. It engages in the manufacturing of probiotics and related applications. The firm also offers the promotion and sale of lactic acid bacteria (LAB) drinks, human health care LAB powder, and agriculture, forestry, fishery and animal husbandry probiotics in China. The company was founded on June 1, 2000 and is headquartered in Kaohsiung City, Taiwan.
Industry
Biotechnology
IPO Date
2023-12-13
Stock Exchange
TWO
Ticker
1295.TWO
According to Synbio Tech Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 19.85. This represents a change of 10.10% compared to the average of 18.03 of the last 4 quarters.
The mean historical PE Ratio of Synbio Tech Inc. over the last ten years is 18.88. The current 19.85 PE Ratio has changed 10.41% with respect to the historical average. Over the past ten years (40 quarters), 1295.TWO's PE Ratio was at its highest in in the September 2023 quarter at 29.87. The PE Ratio was at its lowest in in the December 2022 quarter at 0.
Average
18.88
Median
18.19
Minimum
13.82
Maximum
25.81
Discovering the peaks and valleys of Synbio Tech Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 75.24%
Maximum Annual PE Ratio = 25.81
Minimum Annual Increase = -36.77%
Minimum Annual PE Ratio = 13.82
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | 13.82 | -36.77% |
| 2023 | 21.86 | -15.31% |
| 2022 | 25.81 | 75.24% |
| 2021 | 14.73 | -19.03% |
The current PE Ratio of Synbio Tech Inc. (1295.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
20.50
5-year avg
18.88
10-year avg
18.88
Synbio Tech Inc.’s PE Ratio is greater than Syngen Biotech Co.,Ltd. (12.37), less than 3D Global Biotech Inc. (29.27), greater than Apex Biotechnology Corp. (19.12), greater than BRIM Biotechnology, Inc. (-15.95), greater than SYN-TECH Chem. & Pharm. Co., Ltd. (11.39), greater than TWi Biotechnology, Inc. (-10.75), greater than Energenesis Biomedical CO.,LTD. (-13.33), greater than Senhwa Biosciences, Inc. (-12.86), greater than Maxigen Biotech Inc. (18.87), less than G&E Herbal Biotechnology Co., Ltd. (24.22),
| Company | PE Ratio | Market cap |
|---|---|---|
| 12.37 | $3.46B | |
| 29.27 | $3.75B | |
| 19.12 | $3.14B | |
| -15.95 | $3.70B | |
| 11.39 | $3.39B | |
| -10.75 | $2.04B | |
| -13.33 | $3.81B | |
| -12.86 | $3.59B | |
| 18.87 | $3.94B | |
| 24.22 | $2.99B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synbio Tech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synbio Tech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Synbio Tech Inc.'s PE Ratio?
How is the PE Ratio calculated for Synbio Tech Inc. (1295.TWO)?
What is the highest PE Ratio for Synbio Tech Inc. (1295.TWO)?
What is the 3-year average PE Ratio for Synbio Tech Inc. (1295.TWO)?
What is the 5-year average PE Ratio for Synbio Tech Inc. (1295.TWO)?
How does the current PE Ratio for Synbio Tech Inc. (1295.TWO) compare to its historical average?